TickerTain — Make Analysis Fun Again

TickerTain

←

▶ 19:28 · $ACCEL · Excel led Series B and C for patient, long-term orientation

episode shorts · 3

AI is Speeding Up Everything. Should You?

When Fundraising Backfires

Why Small Teams Build Better Products

now playing · $ACCEL

$LINEARbullish· high· poskarri saarinen

Linear compounds efficiently: ~$80M raised, default alive since year 2, doubling revenue yearly

Linear has raised only ~$70-80M across three rounds, reached default alive within two years, and doubles revenue annually with a tiny team (120 people at $10-15M ARR at Series B),…

$ACCELbullish· high· poskarri saarinen

Excel led Series B and C for patient, long-term orientation

Linear chose Excel for Series B and C because they are a large, established firm that doesn't care about markups and simply wants the company to be best-in-class in its market.

$SEQUOIAbullish· high· poskarri saarinen

Sequoia chosen for seed and Series A for patient capital and founder alignment

Karri Saarinen selected Sequoia for Linear's first two rounds because they align with a long-term, patient approach and don't pressure for markups; he deliberately chose a less ex…